A Phase 3 Large International Noninferiority Trial (MPOWERED): Assessing Maintenance of Response to Oral Octreotide Capsules in Comparison to Injectable Somatostatin Receptor Ligands

Background: MPOWERED, a large phase 3 trial, assessed maintenance of response to oral octreotide capsules (OOC; MYCAPSSA(®)) compared to injectable somatostatin receptor ligands (iSRLs) in patients with acromegaly who responded to OOC and iSRLs (octreotide or lanreotide). OOC were recently approved...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleseriu, Maria, Dreval, Alexander V, Pokramovich, Yulia, Bondar, Irina, Isaeva, Elena, Molitch, Mark E, Macut, Djuro P, Leonova, Nina, Raverot, Gerald, Grineva, Elena, Poteshkin, Yury E, Gilgun-Sherki, Yossi, Ludlam, William H, Patou, Gary, Haviv, Asi, Gordon, Murray B, Biermasz, Nienke, Melmed, Shlomo K, Strasburger, Christian J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090626/
http://dx.doi.org/10.1210/jendso/bvab048.1056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090626/
http://dx.doi.org/10.1210/jendso/bvab048.1056

Ejemplares similares